Group One Trading
ALXO icon

Group One Trading’s ALX Oncology ALXO Stock Holding History

Group One Trading’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-518
Closed -$987 – 7546
2025
Q4 		$585 Buy
+518
New +$784 ﹤0.01% 7787
2025
Q3 		– Sell
-5,194
Closed -$4.5K – 8328
2025
Q2 		$2.16K Sell
5,194
-11,891
-70% -$6K ﹤0.01% 7400
2025
Q1 		$10.6K Buy
17,085
+1,973
+13% +$2.37K ﹤0.01% 6221
2024
Q4 		$25.2K Sell
15,112
-203
-1% -$312 ﹤0.01% 5544
2024
Q3 		$27.9K Buy
+15,315
New +$56.9K ﹤0.01% 5046
2023
Q4 		– Sell
-1,932
Closed -$18.3K – 7316
2023
Q3 		$9.27K Buy
1,932
+600
+45% +$3.26K ﹤0.01% 6375
2023
Q2 		$10K Buy
+1,332
New +$8.72K ﹤0.01% 6393
2022
Q3 		– Sell
-100
Closed -$1K – 7484
2022
Q2 		$1K Hold
100
– – ﹤0.01% 7502
2022
Q1 		$2K Hold
100
– – ﹤0.01% 7698
2021
Q4 		$2K Hold
100
– – ﹤0.01% 7854
2021
Q3 		$7K Buy
+100
New +$6.67K ﹤0.01% 7622

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Group One Trading's ALXO Position: Q1 2026 in Review

Group One Trading sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 518 shares — an estimated $987 sold.

Group One Trading first reported a position in ALXO in Q3 2021 and held it in 11 quarters. The position peaked at $27.9K in Q3 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Group One Trading reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 518 ALX Oncology shares in Q1 2026, an estimated $987.
  • Group One Trading first reported a position in ALX Oncology in Q3 2021 and held it in 11 quarters.
  • Group One Trading's ALX Oncology position peaked at $27.9K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.